Kampala

Kampala is rapidly emerging as a premier East African life sciences hub, strategically positioning itself as a leader in pharmaceutical manufacturing and biotechnology research.

The city is home to the prestigious Makerere University, which anchors the ecosystem through cutting-edge academic research and the Social Innovation in Health Initiative (SIHI).

Kampala is best known for its robust clinical trial infrastructure, led by institutions like the Joint Clinical Research Centre (JCRC), which is currently pioneering advanced cell and gene therapy for HIV and recently launched the country's first bone marrow transplant centre.

The pharmaceutical sector has seen a significant shift toward domestic production, with major players like Cipla Quality Chemical Industries manufacturing essential antiretrovirals (ARVs) and anti-malarials for the regional market.

Healthcare innovation is flourishing within the city’s vibrant startup scene, where healthtech firms like The Medical Concierge Group are digitizing patient care and supply chains.

As a gateway to the East African Community (EAC), Kampala offers lucrative opportunities for medical device distribution and contract manufacturing organizations (CMOs) focused on diagnostic tools and medical consumables.

The Uganda National Drug Authority (NDA) continues to strengthen regulatory frameworks, ensuring that biopharmaceutical ventures meet WHO-GMP standards.

Furthermore, the city’s commitment to pandemic preparedness and local vaccine manufacturing is attracting substantial foreign direct investment (FDI).

With a growing pool of skilled biological scientists and a supportive innovation ecosystem, Kampala is a vital destination for global life sciences stakeholders looking to impact the African continent.